Albumin-based nanocomposite spheres for advanced drug delivery systems

Biotechnology Journal

Volumn 9, Issue 1, 2014, Pages 163-170

  Misak, Heath E ^a   Asmatulu, Ramazan ^a   Gopu, Janani S ^a   Man, Ka Poh ^b   Zacharias, Nora M ^b   Wooley, Paul H ^c   Yang, Shang You ^b,c  

^a Wichita State University   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

^c Orthopaedic Research Institute Incorporated   (United States)

Author keywords

Drug; Human serum albumin; Magnetic nanoparticles; Poly(lactic co glycolic acid); Submicrometer spheres

Indexed keywords

DRUG; HUMAN SERUM ALBUMINS; MAGNETIC NANO-PARTICLES; POLY LACTIC-CO-GLYCOLIC ACID; SUBMICROMETERS;

BIOCOMPATIBILITY; DISEASES;

DRUG DELIVERY;

HUMAN SERUM ALBUMIN; MAGNETITE NANOPARTICLE; MICROSPHERE; POLYGLACTIN;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SKIN CANCER; VISCOSITY;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; LACTIC ACID; MAGNETITE NANOPARTICLES; METHOTREXATE; MICE; MODELS, MOLECULAR; NANOCOMPOSITES; POLYGLYCOLIC ACID; SERUM ALBUMIN;

EID: 84891923721     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201300150     Document Type: Article

References (23)

1. Peters, T., All about albumin: biochemistry, genetics, and medical applications, Academic Press, San Diego 1996.
2. Wunder, A., Muller-Ladner, U., Stelzer, E. H., Funk, J. et al., Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J. Immunol. 2003, 170, 4793-4801.
3. Stehle, G., Sinn, H., Wunder, A., Schrenk, H. H., Plasma protein (albumin) catabolism by the tumor itself-implications for tumor metabolism and the genesis of cachexia. Crit. Rev. Oncol. Hematol. 1997, 26, 77-100.
4. Wunder, A., Stehle, G., Sinn, H., Schrenk, H., Enhanced albumin uptake by rat tumors. Int. J. Oncol. 1997, 11, 497-507.
5. Andersson, C., Iresjo, B. M., Lundholm, K., Identification of tissue sites for increased albumin degradation in sarcoma-bearing mice. J. Surg. Res. 1991, 50, 156-162.
6. Asmatulu, R., Fakhari, A., Wamocha, H. L., Chu, H. Y. et al., Drug-carrying magnetic nanocomposite particles for potential drug delivery systems. J. Nanotechnol. 2009, doi:10.1155/2009/238536.
7. Murakami, T., Phospholipid nanodisc engineering for drug delivery systems. Biotechnol. J. 2012, 7, 762-767.
8. Cai Lesher-Perez, S., Frampton, J. P., Takayama, S., Microfludic systems: A new toolbox for pluripotent stem cells. Biotechnol. J. 2013, 8, 180-191.
9. Asmatulu, R., Zalich, M. A., Claus, R. O., Riffle, J. S., Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J. Magn. Magn. Mater. 2005, 292, 108-119.
10. Cheng, J., Teply, B. A., Jeong, S. Y., Yim, C. H., Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharm. Res. 2006, 23, 557-564.
11. Emami, J., Hamishehkar, H., Najafabadi, A. R., Gilani, K., Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. J. Microencapsul. 2009, 26, 1-8.
12. Pan, J., Chan, S. Y., Lee, W. G., Kang, L., Microfabricated particulate drug-delivery systems. Biotechnol. J. 2011, 6, 1477-1487.
13. von Burkersroda, F., Schedl, L., Göpferich, A., Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 2002, 23, 4221-4231.
14. Arifin, D. Y., Lee, L. Y., Wang, C. H., Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv. Drug Deliv. Rev. 2006, 58, 1274-1325.
15. Batycky, R. P., Hanes, J., Langer, R., Edwards, D. A., A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 1997, 86, 1464-1477.
16. Polyak, B., Friedman, G., Magnetic targeting for site-specific drug delivery: Applications and clinical potential. Expert Opin. Drug Deliv. 2009, 6, 53-70.
17. Misak, G., Cooper, G., Gopu, G., Man, G. et al., Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model. J. Biotechnol. 2013, 164, 130-136.
18. Wamocha, H. L., Misak, H. E., Song, Z., Chu, H. Y. et al., Cytotoxicity of release products from magnetic nanocomposites in targeted drug delivery. J. Biomater. Appl. 2013, 27, 661-667.
19. Calderbank, P. H., Physical rate processes in inducstrial fermentation. Part I: The interfacial area in gas-liquid contacting with mechanical agitation. Chem. Eng. Res. Design 1958, 36, 443-463.
20. Maples, R.E., Petroleum Refinery Process Economics, PennWell Corp. 2000, 457.
21. Zilberman, M., Grinberg, O., HRP-loaded bioresorbable microspheres: Effect of copolymer composition and molecular weight on microstructure and release profile. J. Biomater. Appl. 2008, 22, 391-407.
22. Xiong, S., Zhao, X., Heng, B. C., Ng, K. W., Loo, J. S.-C., Cellular uptake of poly-(D, L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method. Biotechnol. J. 2011, 6, 501-508.
23. Martin, C., Winet, H., Bao, J. Y., Acidity near eroding polylactide-polyglycolide in vitro and in vivo in rabbit tibial bone chambers. Biomaterials 1996, 17, 2373-2380.